Geron

GERN

GERN Geron NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    GERN Chart
    See on advanced chart >

    About

    Geron Corporation was incorporated in the State of Delaware on November 28, 1990. The company is a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is its product candidate in...
    • Highlight
      A late-stage clinical biopharmaceutical company that develops telomerase-targeted and peptide-drug conjugate therapies for cancers
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/30/1996
    • Established Date
      11/28/1990
    • Full-time Employees
      141
    • Address
      919 East Hillsdale Boulevard Suite 250 Foster City CA 94404
    • Tel
      1-650-4737700
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock